Monopar Therapeutics MNPR Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Monopar Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Monopar Therapeutics’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Monopar Therapeutics's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Monopar Therapeutics's investing cash flow?
- Monopar Therapeutics (MNPR) reported investing cash flow of -$5.58M in Q1 2026.
- How has Monopar Therapeutics's investing cash flow changed year-over-year?
- Monopar Therapeutics's investing cash flow decreased by 1613.7% year-over-year, from -$325.83K to -$5.58M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.